Cardiovascular characterization of SD-3211, a novel benzothiazine calcium channel blocker, in isolated rabbit hearts
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
1984 • 274 citations
Differences in cardiovascular profile among calcium antagonists
1987 • 108 citations
The expert committee of the World Health Organization on classification of calcium antagonists: The viewpoint of the raporteur
1987 • 71 citations
Synthesis and calcium ion antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzothiazines
1990 • 63 citations
Clinical outcome after treatment of rest angina with calcium blockers: Comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil
1983 • 61 citations
Second-generation calcium antagonists: Search for greater selectivity and versatility
1985 • 58 citations
Novel calcium antagonists. Synthesis and structure-activity relationship studies of benzothiazoline derivatives
1988 • 58 citations
Paradoxical angina after nifedipine: Angiographic documentation
1984 • 34 citations
Electrophysiological Properties of SD-3211, a Novel Putative Ca2+ Antagonist, in Isolated Guinea Pig and Rabbit Hearts
1990 • 28 citations
SD-3211, a Novel Benzothiazine Calcium Antagonist, Alone and in Combination with a Beta-Adrenoceptor Antagonist, Produces Antihypertensive Effects Without Affecting Heart Rate and Atrioventricular Conduction in Conscious Renal Hypertensive Dogs
1991 • 19 citations
Electrophysiologic Effects of a Novel Ca Antagonist, SA2572, in Isolated Rabbit and Guinea Pig Hearts
1988 • 6 citations
The antihypertensive effect of a novel Ca++ antagonist, SD-3211, in rats
1989 • 3 citations